57 related articles for article (PubMed ID: 38671431)
1. Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A; Javed AA; Michelakos T; Sekigami Y; Zheng J; Kalvin HL; McIntyre CA; Nebbia M; Chou JF; Gonen M; Raj N; Reidy-Lagunes DL; Zureikat AH; Ferrone CR; He J; Wei AC;
Ann Surg; 2023 Nov; 278(5):e1063-e1067. PubMed ID: 37796750
[TBL] [Abstract][Full Text] [Related]
2. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of pancreatic neuroendocrine tumors: an introduction.
Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
[No Abstract] [Full Text] [Related]
4. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
5. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
6. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
Ge W; Zhou D; Xu S; Wang W; Zheng S
Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
9. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
Kos-Kudła B; Castaño JP; Denecke T; Grande E; Kjaer A; Koumarianou A; de Mestier L; Partelli S; Perren A; Stättner S; Valle JW; Fazio N
J Neuroendocrinol; 2023 Dec; 35(12):e13343. PubMed ID: 37877341
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
Louise M Binderup M; Smerdel M; Borgwadt L; Beck Nielsen SS; Madsen MG; Møller HU; Kiilgaard JF; Friis-Hansen L; Harbud V; Cortnum S; Owen H; Gimsing S; Friis Juhl HA; Munthe S; Geilswijk M; Rasmussen ÅK; Møldrup U; Graumann O; Donskov F; Grønbæk H; Stausbøl-Grøn B; Schaffalitzky de Muckadell O; Knigge U; Dam G; Wadt KA; Bøgeskov L; Bagi P; Lund L; Stochholm K; Ousager LB; Sunde L
Eur J Med Genet; 2022 Aug; 65(8):104538. PubMed ID: 35709961
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review.
Okawa Y; Tsuchikawa T; Hatanaka KC; Matsui A; Tanaka K; Nakanishi Y; Asano T; Noji T; Nakamura T; Mitsuhashi T; Okamura K; Hatanaka Y; Hirano S
Pancreas; 2022 Apr; 51(4):338-344. PubMed ID: 35699685
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
[TBL] [Abstract][Full Text] [Related]
13. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
14. Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors.
Gudmundsdottir H; Graham RP; Sonbol MB; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Habermann EB; Halfdanarson TR; Cleary SP
J Surg Oncol; 2021 Dec; 124(7):1077-1084. PubMed ID: 34310723
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
